0
Signin
countryflagUK

8082-737-676

0R15 7793.0 0.1028% 0R1E 7575.0 -1.8782% 0M69 None None% 0R2V 184.5 6.0345% 0QYR 1387.5 0.7991% 0QYP 405.5 -0.7344% 0LCV 141.03 0.952% 0RUK None None% 0RYA 1733.01 -1.0839% 0RIH 165.3 0.3643% 0RIH 165.3 0.3643% 0R1O 186.6 9945.7604% 0R1O None None% 0QFP None None% 0M2Z 299.0593 0.5664% 0VSO None None% 0R1I None None% 0QZI 450.5 2.7366% 0QZ0 220.0 0.0% 0NZF None None%

Small-Cap

Are you an investor that on the lookout for financially sound for companies that have operated for many years and have dependable earnings, often paying dividends to investors? You are the right place

|
One NASDAQ- Listed Financial Stock at Resistance Level: LendingTree Inc
Team Kalkine

One NASDAQ- Listed Financial Stock at Resistance Level: LendingTree Inc

  • May 02, 2024
  •   | Read Time : 5 min
Technical Analysis on One NYSE- Listed REIT Stock- MDV
Team Kalkine

Technical Analysis on One NYSE- Listed REIT Stock- MDV

  • May 02, 2024
  •   | Read Time : 5 min
Key Business Insights on One Residential Housebuilder Stock - CRST
Team Kalkine

Key Business Insights on One Residential Housebuilder Stock - CRST

  • May 02, 2024
  •   | Read Time : 10 Mins
An Update on Utility Supplier Company – TEP
Team Kalkine

An Update on Utility Supplier Company – TEP

  • May 02, 2024
  •   | Read Time : 10 Mins
Technical Analysis on One NASDAQ- Listed Stock- VFF
Team Kalkine

Technical Analysis on One NASDAQ- Listed Stock- VFF

  • May 01, 2024
  •   | Read Time : 5 min
Technical Analysis on One NASDAQ- Listed Pharmaceutical Stock- CRON
Team Kalkine

Technical Analysis on One NASDAQ- Listed Pharmaceutical Stock- CRON

  • May 01, 2024
  •   | Read Time : 5 min
Update on NASDAQ-Listed Marine Stock – StealthGas Inc
Team Kalkine

Update on NASDAQ-Listed Marine Stock – StealthGas Inc

  • May 01, 2024
  •   | Read Time : 5 min
Acquisition Agreement Between Kinnate Biopharma Inc. and XOMA Corporation
Team Kalkine

Acquisition Agreement Between Kinnate Biopharma Inc. and XOMA Corporation

  • May 01, 2024
  •   | Read Time : 5 min

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions